Vaccines Europe - 02 Oct 2023
The Vaccines Europe Annual Report highlights how the team has grown over the past 2 years with the addition of new team members and new or increased collaborations with key EU stakeholders. The report also reiterates Vaccines Europe’s position on key policy issues and support to key strategic initiatives.
Our positive development is demonstrated through activities supporting Vaccines Europe’s strategic priorities of innovation, access and value. Our main focus in 2022 was on the prioritisation of adult immunisation policies in Europe as well as improving the attractiveness of the vaccines industry in the EU.
As 2023 comes to a close and 2024 approaches, we are committed to continuing to work on every part of the vaccine ecosystem covering research & innovation, regulatory affairs, manufacturing and supply, market access and public policy, immunisation financing and vaccine acceptance.
Members area
